Literature DB >> 9399007

Headache during pregnancy.

F Maggioni1, C Alessi, T Maggino, G Zanchin.   

Abstract

A questionnaire was submitted to 430 women 3 days after delivery, asking mainly about features of headache before and during pregnancy, and their possible modification or recurrence; moreover, delivery modalities and the condition of the newborn were evaluated. One-hundred-and-twenty-six (29.3%) were found to be primary headache sufferers (IHS criteria, 1988), 81 of whom had migraine without aura (MO), 12 migraine with aura (MA), and 33 tension-type headache (TH). In all three groups, about 80% showed complete remission or a higher than 50% decrease in the number of attacks. The improvement was more evident after the end of the first trimester; this trend was common to the three primary headaches considered. In our series of primary headaches, there was only one case (MO) which began during pregnancy. In a subgroup of pluripara, headache maintained the improvement presented in the first pregnancy also during the following gravidic periods in about 50% of cases, whereas in the remaining 50% a worsening in parallel with successive pregnancies was found. Primary headaches "per se" do not seem to increase the pregnancy or delivery risks, nor the vitality of the newborn. During pregnancy, drug use was very much reduced and was restricted to a limited number of compounds.

Entities:  

Mesh:

Year:  1997        PMID: 9399007     DOI: 10.1046/j.1468-2982.1997.1707765.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  39 in total

Review 1.  Identification of molecular genetic factors that influence migraine.

Authors:  Bridget H Maher; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2011-04-26       Impact factor: 3.291

Review 2.  Migraine during pregnancy: options for therapy.

Authors:  Anthony W Fox; Merle L Diamond; Egilius L H Spierings
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Behavioral effects and mechanisms of migraine pathogenesis following estradiol exposure in a multibehavioral model of migraine in rat.

Authors:  Lydia M M Vermeer; Eugene Gregory; Michelle K Winter; Kenneth E McCarson; Nancy E J Berman
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

4.  [The arduous route of a 33-year-old woman with headache].

Authors:  C Imelauer-Siegner; T Brinkschmidt
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

Review 5.  Sex hormones and primary headaches other than migraine.

Authors:  Doris Lieba-Samal; Christian Wöber
Journal:  Curr Pain Headache Rep       Date:  2011-10

6.  Brain imaging in pregnant women with acute headache.

Authors:  Bianca Raffaelli; Lars Neeb; Heike Israel-Willner; Jeannette Körner; Thomas Liman; Uwe Reuter; Eberhard Siebert
Journal:  J Neurol       Date:  2018-06-11       Impact factor: 4.849

Review 7.  Tolerability of the triptans: clinical implications.

Authors:  Giuseppe Nappi; Giorgio Sandrini; Grazia Sances
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 8.  Migraine in pregnancy: what are the safest treatment options?

Authors:  V Pfaffenrath; M Rehm
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 9.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

10.  Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women.

Authors:  Siri Amundsen; Torunn G Øvrebø; Netta Marie S Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2016-09-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.